Department of Hematology, Oncology and Cancer Immunology | CVK 

Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

Research group Prof. Dr. med. Frederik Damm

The research group of Frederik Damm investigates genetic aberrations of hematologic malignancies. 

You are here:

Focus of research

The research group of Frederik Damm focuses on genetic events defining early steps during leukemo-/ lymphomagenesis using several molecular biology techniques. Combinations of various sequencing technologies using bulk and single-cell approaches help to develop novel models of precision oncology.  A broad national and international collaborating network supports investigations of rare tumor entities and/or molecularly defined subgroups.

Prof. Dr. med. Frederik Damm

Geschäftsführender Oberarzt, Direktor Molekulares Krebsforschungszentrum (MKFZ)

CVK: Campus Virchow-Klinikum

Projects
Team

News and announcements

  • Franziska Briest receives a "Rahel-Hirsch Habilitationsstipendium"
  • Daniel Nörenberg receives the "Lymphoma Biology" Award 2025 from the German Lymphoma Alliance
  • Prof. Damm receives the "Gerhard-Domagk-Preis 2024"
  • Prof. Damm receives the "Publikationspreis 2024 der Else Kröner-Fresenius Stiftung"
  • Daniel Nörenberg receives the "Sebastian-Schwind Nachwuchspreis 2024"
  • Adriane Halik and Christopher Maximilian Arends received an ASH Abstract Achievement Award 2023
  • Our work on PMBCL genetics got selected for oral presentation within the Presidential Symposium at EHA 2022 in Vienna
  • ​​​​​​AG Damm receives "José Carreras Best Paper Award 2020"
  • Prof. Damm receives "Hector Forschungspreis 2020"
  • Dr. Frick receives Curt-Meyer Gedächtnispreis 2019
  • PD Dr. Damm receives DGHO Acute Leukemia Research Award 2019

Selected publications

  • Wiegand L, Silva P, Noerenberg D, ..., Hablesreiter R*, Damm F*. Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin Lymphoma. Blood (2026). doi: 10.1182/blood.2025030489 PubMed
  • Al-Sawaf O*, Locher BN*,  Christen F, ..., Damm F. The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia. Blood (2025). doi: 10.1182/blood.2025029905 PubMed
  • Stein CM, Hablesreiter R, Christen F, ..., Damm F. Dynamics of Clonal Hematopoiesis and Cellular Responses to Stress-Induced Toxicity in Autologous Stem Cell Transplantation. Leukemia (2025). doi: 10.1038/s41375-025-02823-z PubMed
  • Hablesreiter R, Strzelecka PM, Kopp K, ..., Christen F*, Damm F*. Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolution. Exp Hematol Oncol (2025). doi: 10.1186/s40164-025-00718-4 PubMed
  • Kobbe G, Brüggemann M, Baermann BN, ... Damm F*, Dietrich S*. Aggressive lymphoma after CD19 CAR T-Cell Therapy. New Engl J Med (2024). DOI:10.1056/NEJMoa2402730 PubMed
  • Halik A, Tilgner M, Silva P, ..., Damm F. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. Journal of Hematology & Oncology (2024). 
    doi: 10.1186/s13045-024-01590-1 PubMed
  • Arends CM, Kopp K, Hablesreiter R, ..., Damm F. Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia (2024). doi: 10.1038/s41375-024-02253-3. PubMed
  • Noerenberg D, Briest F, Hennch C, ..., Damm F. Genetic Characterization of Primary Mediastinal B-cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of Clinical Oncology (2023). doi: 10.1200/JCO.23.01053. PubMed
  • Panagiota D, Kerschbaum JF, Penack O, ..., Damm F. Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients. Hemasphere (2023). doi: 10.1097/HS9.0000000000000957. PubMed
  • Briest F, Noerenberg D, Hennch C, ..., Damm F. Freqeunt ZNF217 mutaitons lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. Leukemia (2023). doi: 10.1038/s41375-023-02013-9. PubMed
  • Arends CM, Liman TG, Strzelecka PM, ..., Damm F. Associations of clonal haematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke. Blood (2022). doi: 10.1182/blood.2022017661 PubMed
  • Arends CM, Dimitriou S, Stahler A, ..., Damm F. Clonal hematopoiesis associates with improved survival in metastatic colorectal cancer patients from the FIRE-3 trial. Blood (2022). doi: 10.1182/blood.2021014108 PubMed
  • Christen F, Hablesreiter R, Hoyer K, ..., Damm F. Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9. Leukemia (2022). doi: 10.1038/s41375-021-01469-x PubMed
  • Hoyer K, Hablesreiter R, Inoue Y, ..., Damm F. A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial. EBioMedicine (2021). doi: 10.1016/j.ebiom.2021.103327 PubMed
  • Mylonas E, Yoshida K, Frick M, ..., Damm F. Single-cell analysis based dissection of clonality in myelofibrosis. Nature Communications (2020). doi: 10.1038/s41467-019-13892-x PubMed
  • Christen F, Hoyer K, Yoshida K, ..., Damm F. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. Blood (2019). doi: 10.1182/blood-2018-05-852822 PubMed
  • Frick M, Chan W, Arends CM, ..., Damm F. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology (2019). doi: 10.1200/JCO.2018.79.2184 PubMed
  • Arends CM, Galan-Sousa J, Hoyer K, …, Damm F. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis. Leukemia (2018). doi:10.1038/s41375-018-0047-7 PubMed
  • Young E, Noerenberg D, Mansouri L, ..., Damm F. EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. Leukemia 31, 1547–1554 (2017). doi:10.1038/leu.2016.359 PubMed
  • Mansouri L, Noerenberg D, Young E, ..., Damm F. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood 128, 2666–2670 (2016). doi:10.1182/blood-2016-03-704528 PubMed
  • Damm F, Mylonas E, Cosson A, et al. Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients. Cancer Discovery 4, 1088–1101 (2014). doi:10.1158/2159-8290.CD-14-0104 PubMed

Funding sources